Enterosgel IBS Treatment Claim Fails UK Review Following J&J Ltd. Complaint
This article was originally published in The Rose Sheet
Executive Summary
EnteroMed fails to provide adequate support for ad claims that its supplement gel absorbs toxins and treats gastrointestinal issues, including IBS, the UK Advertising Standards Authority says. A J&J UK subsidiary marketing competing consumer health products was among the complainants about the firm's ads.